Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
62.931,04
-1,27%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni Italia BIT Sanofi (1SAN) Sanofi (1SAN) Notizie

Sanofi

1SAN
90,99
-0,64 (-0,70%)
26 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Italia
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
25/4/202407:30GLOBEPress Release: Sanofi Q1: robust 7% sales growth driven by..
23/4/202407:00GLOBEPress Release: Rilzabrutinib LUNA 3 phase 3 study met..
17/4/202407:00GLOBEPress Release: New 48-week frexalimab phase 2 data support..
12/4/202420:05GLOBESanofi: Informations relatives au nombre de droits de vote..
08/4/202418:00GLOBESanofi - AGM 30.04.2024 - Availability of Preparatory..
22/3/202407:30GLOBEPress Release: Availability of the Q1 2024 Memorandum for..
15/3/202420:04GLOBESanofi: Information concerning the total number of voting..
11/3/202407:00GLOBECommuniqué de presse : De nouveaux résultats de phase II..
24/2/202415:51GLOBECommuniqué : Résultats de phase II montrent que le..
23/2/202418:45GLOBECommuniqué de presse : Dépôt du Document d’Enregistrement..
23/2/202407:00GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
22/2/202419:02GLOBEPress Release: Sanofi’s Board of Directors proposes the..
20/2/202423:40GLOBESanofi: Information concerning the total number of voting..
16/2/202407:00GLOBECommuniqué de presse : Le Japon est le premier pays dans le..
15/2/202414:00GLOBEPress Release: Phase 2 data published in NEJM show potential..
05/2/202408:00GLOBECommuniqué de presse : Entraide, conditions de travail..
01/2/202407:30GLOBECommuniqué de presse : François-Xavier Roger nommé Directeur..
25/1/202420:30GLOBEPress Release: Dupixent® FDA approved as first and only..
23/1/202407:30GLOBEPress Release: Sanofi to acquire Inhibrx, Inc., adding..
17/1/202422:57GLOBESanofi: Informations relatives au nombre de droits de vote..
09/1/202407:30GLOBEPress Release: Brian Foard appointed Head of Specialty Care..
21/12/202307:30GLOBECommuniqué de presse : Sanofi annonce la fin du programme..
18/12/202321:59GLOBESanofi: Information concerning the total number of voting..
15/12/202307:30GLOBEPress Release: Availability of the Q4 2023 Memorandum for..
15/12/202307:00GLOBECommuniqué de presse : L’EMA a rendu un avis favorable pour..
11/12/202322:08GLOBECommuniqué de presse : Déclaration au sujet de la..
11/12/202301:30GLOBEPress Release: Sarclisa® (isatuximab) plus KRd significantly..
07/12/202307:35GLOBECP : L’essai de phase III consacré au Sarclisa® (isatuximab)..
07/12/202303:30GLOBECommuniqué de presse : Sanofi sur la voie du leadership..
27/11/202307:30GLOBECommuniqué de presse : Dupixent® a permis de réduire..
23/11/202318:00GLOBESanofi: Information concerning the total number of voting..
27/10/202307:31GLOBECommuniqué de presse : Un troisième trimestre solide, marqué..
27/10/202307:30GLOBEPress Release: Sanofi Enters Next Chapter of Play to Win..
22/10/202321:00GLOBEPress Release: Dupixent® (dupilumab) Phase 3 Results show..
19/10/202312:00GLOBEPress Release: Sanofi delivers first medicines from Global..
18/10/202310:45GLOBECommuniqué de presse : Des données de ph III présentées au..
17/10/202320:18GLOBESanofi: Information concerning the total number of voting..
13/10/202316:00GLOBEPress Release: Late-breaking amlitelimab Phase 2b data..
04/10/202307:00GLOBEPress Release: Sanofi and Teva announce exclusive..
03/10/202307:30GLOBECommuniqué de presse : Sanofi annonce un accord sur un..
26/9/202307:30GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
25/9/202309:00GLOBECommuniqué de presse : ALTUVIIIO® une fois par semaine, une..
22/9/202307:30GLOBECommuniqué de presse : Mise en ligne du document « Q3 2023..
19/9/202308:30GLOBEPress Release: Sanofi supporting vulnerable communities as..
11/9/202320:02GLOBESanofi: Informations relatives au nombre de droits de vote..
31/8/202307:30GLOBECommuniqué de presse: Sanofi annonce des changements au sein..
15/8/202321:24GLOBESanofi: Information concerning the total number of voting..
03/8/202321:21GLOBEPress Release: U.S. CDC Advisory Committee unanimously..
28/7/202313:22GLOBEPress release: Online availability of Sanofi’s half-year..
28/7/202307:32GLOBECommuniqué de presse : Sanofi va acquérir Qunol®, une marque..
Apertura: 91,55 Min: 89,84 Max: 91,55
Chiusura: 91,63

La tua Cronologia

BIT
1SAN
Sanofi
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network